Body fat and higher BMIs have been associated with a higher risk of developing rheumatoid arthritis
and for those tesamorelin-treated patients completing the 26-week treatment period that were re-randomized to tesamorelin (T-T group) or re-randomized to placebo, 48.9% and 50.6%, respectively, had impaired glucose tolerance, while 4.3% re-randomized to tesamorelin and 12.9% re-randomized to placebo had diet-controlled diabetes mellitus
Jastreboff AM, Kaplan LM, Fras JP, Wu Q, Du Y, Gurbuz S, et al
Sinha, R., Sinha, I., Calcagnotto, A., Trushin, N., Haley, J
Peer review Peer review information Nature Reviews Cardiology thanks Stephen Bain and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Get Started We'll get back to you within 24 hours What Is Glutathione